Charcot-Marie-Tooth Neuropathy Type 1D (CMT1D)

Charcot-Marie-Tooth neuropathy type 1D (CMT1D) is a rare, inherited nerve disease that mainly damages the long nerves going to the feet, legs, hands, and arms. It is a “demyelinating” neuropathy, which means the myelin coating around the nerves is damaged, so nerve signals travel much more slowly than normal. CMT1D is caused by harmful changes (mutations) in a gene called EGR2. This gene helps the cells that make myelin (Schwann cells) build and maintain a healthy myelin sheath. When EGR2 does not work properly, the myelin becomes weak or breaks down, and over time this leads to muscle weakness, wasting, and problems with walking and balance. MalaCards+1

Charcot-Marie-Tooth neuropathy type 1D (CMT1D) is a rare inherited nerve disease that mainly affects the long nerves in the legs and arms. It causes slow, progressive weakness, muscle wasting, foot deformities and loss of feeling, especially in the feet and hands. There is no cure or disease-stopping drug yet. Treatment focuses on protecting nerves, reducing pain, preventing deformity and helping you stay mobile and independent for as long as possible. This usually means a mix of physical therapy, braces, surgery for severe deformities, plus medicine for neuropathic (nerve) pain and cramps. nhs.uk+3Physiopedia+3Mayo Clinic+3

Other names

Doctors and researchers use several other names for Charcot-Marie-Tooth neuropathy type 1D. It may be called CMT1D, Charcot-Marie-Tooth disease type 1D, Charcot-Marie-Tooth neuropathy type 1D, hereditary motor and sensory neuropathy type 1D (HMSN1D), or hereditary motor and sensory neuropathy ID. Some texts also write “Charcot-Marie-Tooth disease type 1 caused by mutation in EGR2,” to highlight that the EGR2 gene is the main cause. All these names describe the same genetic nerve disorder. MalaCards+1

Types of Charcot-Marie-Tooth neuropathy type 1D

Even though CMT1D is one specific genetic subtype, it can appear in different clinical forms. Doctors sometimes describe “types” based on age when symptoms start and how severe they are. These are not official separate diseases, but useful ways to describe the range of CMT1D. Orpha+1

1. Infant-onset severe CMT1D – In this form, signs appear in the first years of life. Babies or toddlers may be slow to sit, stand, or walk. They may have very weak leg muscles and very slow nerve conduction on tests. This form can overlap with severe conditions such as Dejerine–Sottas neuropathy or congenital hypomyelinating neuropathy. Nature+1

2. Childhood-onset classical CMT1D – Here, symptoms begin in school-age years. Children may run slowly, trip often, or develop high-arched feet. Weakness and wasting of the small muscles in the feet and lower legs slowly progress over many years. Nerve conduction studies show clearly reduced speeds, typical of demyelinating CMT. Orpha+1

3. Adolescent-onset CMT1D – In this type, symptoms first appear in the teenage years. The course is often slowly progressive. Teenagers notice difficulty in sports, ankle sprains, and hand weakness when doing fine tasks. This pattern can look similar to other CMT1 subtypes, so genetic testing is needed to confirm EGR2 involvement. MalaCards+1

4. Adult-onset mild CMT1D – Some people do not have obvious symptoms until adulthood. They may notice numbness, mild weakness, or foot deformities later in life. In a few families, EGR2 mutations cause relatively mild and slowly progressive neuropathy, and diagnosis may be delayed for many years. Ovid+1

5. Complex CMT1D with central nervous system signs – Rare EGR2 mutations can cause not only peripheral neuropathy but also additional problems, such as stiffness, increased reflexes, or other central nervous system signs. These cases show that EGR2-related neuropathies can have a wide and complex range of features. Mattioli 1885+1

Causes

1. Pathogenic mutation in the EGR2 gene – The main cause of CMT1D is a harmful mutation in the EGR2 gene on chromosome 10. EGR2 is a transcription factor that controls many genes needed for building and keeping healthy myelin in peripheral nerves. When this gene is changed, myelin becomes abnormal and nerve signals slow down. MalaCards+1

2. Autosomal dominant inheritance – CMT1D is usually inherited in an autosomal dominant way. This means a child needs only one copy of the changed gene from one parent to develop the disease. Often, many people across generations in the same family are affected. MalaCards+1

3. De novo EGR2 mutations – Sometimes CMT1D appears in a person with no clear family history. In these cases, the EGR2 mutation may be “de novo,” meaning it happened for the first time in the egg or sperm or very early in development. Nature+1

4. Mutations in crucial EGR2 protein domains – Many reported mutations affect important parts of the EGR2 protein, such as zinc finger regions that bind DNA. These changes weaken the protein’s ability to switch on myelin genes, causing poor myelin formation and demyelination. ScienceDirect+1

5. Disruption of Schwann cell differentiation – EGR2 is central for Schwann cell maturation. When it is not working correctly, Schwann cells stay in an immature state and cannot wrap axons with thick, stable myelin, which leads to chronic demyelinating neuropathy. Wikipedia+1

6. Abnormal regulation of myelin structural proteins – Faulty EGR2 signaling can disturb the production of myelin proteins such as myelin protein zero and peripheral myelin protein 22. This imbalance damages the structure and function of the myelin sheath. Wikipedia+1

7. Segmental demyelination of peripheral nerves – Over time, the abnormal myelin breaks down in small segments along the nerve. This segmental demyelination slows nerve conduction and is a key pathologic process in CMT1D. MalaCards+1

8. Repeated demyelination and remyelination – Nerves try to repair damaged myelin, but the repair is imperfect. Repeated cycles of myelin loss and regrowth cause “onion bulb” formations seen on nerve biopsy and contribute to chronic nerve dysfunction. MalaCards+1

9. Distal axonal degeneration as a downstream effect – When myelin is repeatedly damaged, the underlying axons can also degenerate, especially in the longest nerves to the feet and hands. This axonal loss leads to permanent weakness and wasting. MalaCards+1

10. Genetic heterogeneity within EGR2-related neuropathies – Different EGR2 mutations can cause a spectrum of diseases, from classic CMT1D to Dejerine–Sottas and congenital hypomyelinating neuropathy. The specific mutation can influence age at onset and disease severity. Nature+1

11. Compound genetic factors – Rarely, a person may carry an EGR2 mutation plus another neuropathy gene mutation (for example in GJB1). Having mutations in two different genes can make the neuropathy more severe. ResearchGate+1

12. Family clustering and shared genetic background – In some families, several members with the same EGR2 mutation show slightly different severity. This suggests that other genes and shared family genetics can modify how strongly CMT1D appears. Wiley Online Library+1

13. Possible influence of hormonal or metabolic factors – Experimental work in CMT suggests that hormones and metabolic pathways can affect myelin stability. Although not a direct cause, these pathways may modify how EGR2 mutations express disease over time. ResearchGate+1

14. Early life nerve development disruption – EGR2 is important during development of the peripheral nervous system. Mutations may disrupt normal myelination from very early life, leading to infant or childhood onset of symptoms. Wikipedia+1

15. Progressive myelin instability with aging – As a person ages, nerves naturally face more stress. With an EGR2 mutation, the already fragile myelin may slowly fail, which can explain late-onset or worsening symptoms in adulthood. Ovid+1

16. Autosomal dominant transmission without full penetrance – In some families, not everyone who carries the EGR2 mutation shows strong symptoms. This incomplete penetrance still means the mutation is the cause, but other factors can hide or lessen the clinical signs. MalaCards+1

17. Rare large deletions or structural changes around EGR2 – In addition to small point mutations, larger genetic changes involving the EGR2 region can disturb normal gene expression and cause demyelinating neuropathy similar to CMT1D. Nature+1

18. Epigenetic changes affecting EGR2 expression – Research suggests that epigenetic mechanisms (chemical tags on DNA) can influence how strongly genes are expressed. Abnormal regulation of EGR2 expression might contribute to the variability of disease severity. Nature+1

19. Environmental stress acting on vulnerable nerves – Factors such as repeated nerve compression, poor footwear, or other illnesses do not cause CMT1D directly but can worsen symptoms because the nerves are already fragile from the EGR2 mutation. MalaCards+1

20. Random biologic variation – Even with the same mutation, people can show different levels of damage due to random biological differences in development and repair. This normal variation is part of the reason why the same genetic cause can look different from person to person. Wiley Online Library+1

Symptoms

1. Gait problems and frequent tripping – One of the earliest signs is trouble with walking. People may trip often, catch their toes on the ground, or feel unsteady on uneven surfaces. This happens because the muscles that lift the front of the foot become weak, a problem known as foot drop. Orpha+1

2. Weakness in the feet and lower legs – Over time, the small muscles in the feet and calves become weak and thin. This makes it hard to stand on the heels, run, or climb stairs. The weakness is usually worse in the outer and front parts of the lower leg. NCBI+1

3. Foot deformities (high arches and hammer toes) – Many people with CMT1D develop high-arched feet (pes cavus) and toes that curl (hammer toes). These deformities come from long-standing muscle imbalance between weak and relatively stronger muscles in the foot and ankle. MalaCards+1

4. Weakness in the hands and forearms – As the disease progresses, the small muscles of the hands can become weak. This makes it hard to do fine tasks like buttoning clothes, writing, or opening jars. Hand weakness often appears later than foot weakness. NCBI+1

5. Distal muscle wasting – The muscles furthest from the body (distal muscles) become noticeably thinner. The lower legs can look like “inverted champagne bottles,” with thin calves compared to the thighs. This wasting reflects long-term nerve and muscle damage. NCBI+1

6. Numbness and reduced feeling – Many people notice numbness, tingling, or “pins and needles” in the feet and hands. They may have trouble feeling light touch, pain, or temperature. This happens because sensory nerve fibers are damaged. Orpha+1

7. Loss of vibration and position sense – The ability to feel vibration (for example from a tuning fork) and to know where the joints are in space can be reduced. This makes it harder to keep balance, especially in the dark or with eyes closed. NCBI+1

8. Absent or reduced reflexes – When a doctor tests reflexes at the ankles or knees, they are often weak or absent in CMT1D. This is a typical sign of chronic peripheral neuropathy and reflects slow or blocked reflex pathways in the damaged nerves. MalaCards+1

9. Steppage gait – People may walk by lifting their knees higher than normal, like climbing stairs, to prevent the toes from dragging. This is called a steppage gait and is a classic sign of foot drop from peroneal muscle weakness. NCBI+1

10. Muscle cramps and fatigue – Legs and feet can cramp or feel tight, especially after walking. Because the muscles are weak and the nerves are inefficient, everyday activities can cause tiredness and aching in the limbs. MalaCards+1

11. Neuropathic pain or discomfort – Some people experience burning, shooting, or electric-like pain in the feet or legs. Others may feel deep aching or unpleasant sensations. These pains come from irritated or damaged sensory nerves. MalaCards+1

12. Balance problems and falls – Poor sensation in the feet and weakness of ankle muscles make it hard to keep balance, especially on uneven ground. People may have a wide-based walk and may fall more often than others. Orpha+1

13. Scoliosis and posture changes – In some cases, the spine curves abnormally (scoliosis), and posture may become stooped. This is thought to arise from long-term muscle imbalance and weakness in the trunk and paraspinal muscles. Orpha+1

14. Cranial nerve involvement (rare) – Rarely, CMT1D can affect cranial nerves. This may cause double vision, facial weakness, or problems moving the eyes. These features show that some EGR2 mutations can involve nerves beyond the limbs. Orpha+1

15. Bilateral vocal cord paresis (rare) – A few reports describe people with CMT1D who have weakness of the vocal cords. This can cause a hoarse voice, breathing difficulty, or noisy breathing (stridor). Although uncommon, it is a recognized feature of some EGR2 mutations. Orpha+1

Diagnostic tests

Physical examination

1. Detailed medical and family history with neurologic exam – The doctor first asks about symptoms, age at onset, and similar problems in family members. They then perform a full neurologic exam, checking strength, sensation, reflexes, and coordination. The pattern of distal weakness and sensory loss, with reduced reflexes, strongly suggests hereditary neuropathy like CMT1D. Orpha+1

2. Gait and posture assessment – The clinician watches the person walk, run if possible, stand on heels and toes, and turn quickly. They look for foot drop, high-stepping gait, ankle instability, and difficulty with heel walking. This helps judge how much the neuropathy affects everyday movements. NCBI+1

3. Inspection of feet, hands, and spine – The doctor carefully examines the shape of the feet (high arches, flat feet, hammer toes), the hands (wasting between the thumb and index finger), and the spine (curves or scoliosis). These visible changes provide important clues to a long-standing neuropathy such as CMT1D. Orpha+1

4. Reflex testing and coordination checks – Reflexes at the ankles and knees are tested with a reflex hammer, and coordination is checked with tasks like touching the finger to the nose. In CMT1D, reflexes are usually reduced or absent, while coordination in the arms may remain relatively preserved. NCBI+1

Manual bedside tests

5. Manual muscle testing (MRC grading) – The examiner tests strength by asking the person to move joints against resistance, such as lifting the foot up or spreading the toes. Strength is graded using the Medical Research Council (MRC) scale from 0 to 5. In CMT1D, distal muscles usually grade lower than proximal muscles. NCBI+1

6. Light touch and pinprick sensory testing – Using cotton wool, a soft brush, or a small pin, the clinician checks how well the person feels light touch and pain across the feet, legs, hands, and arms. Reduced feeling in a “glove and stocking” pattern supports the diagnosis of length-dependent peripheral neuropathy. Orpha+1

7. Vibration and joint position sense tests – A tuning fork is placed on the ankles and toes to see if vibration can be felt, and the examiner gently moves the toes or fingers up and down to test position sense. Impaired vibration and joint position sense are common in demyelinating CMT and contribute to balance problems. NCBI+1

8. Balance tests (Romberg and tandem gait) – In the Romberg test, the person stands with feet together and eyes closed to see if they sway. In tandem gait, they walk heel-to-toe in a straight line. Difficulty with these tasks suggests loss of sensory feedback from the feet, which fits with chronic neuropathy. NCBI+1

Laboratory and pathological tests

9. Basic blood tests (screening for other neuropathy causes) – Blood tests such as complete blood count, kidney and liver function, and markers for diabetes or infection help rule out other common causes of neuropathy. While these tests do not confirm CMT1D, they are important to be sure there is not a treatable alternative cause. Charcot-Marie-Tooth Association+1

10. Tests for metabolic and immune causes of neuropathy – Doctors may order blood sugar, HbA1c, vitamin B12, thyroid function tests, and sometimes tests for autoimmune or inflammatory disease. Normal results support the suspicion of a hereditary neuropathy rather than an acquired one. Charcot-Marie-Tooth Association+1

11. Serum protein studies – In some adults with neuropathy, serum protein electrophoresis or immunofixation is done to exclude conditions like monoclonal gammopathy or amyloidosis. Again, these tests are usually normal in CMT1D and help exclude other causes. Charcot-Marie-Tooth Association+1

12. Genetic counseling evaluation – A genetics professional takes a detailed family tree, explains inheritance patterns, and helps select the best genetic tests. This step is important for understanding the risk to other family members and planning testing in a safe and informed way. MalaCards+1

13. Targeted genetic testing for EGR2 and CMT panels – The most specific test for CMT1D is DNA testing that looks for mutations in EGR2, often as part of a broader CMT gene panel. Finding a pathogenic EGR2 mutation confirms the diagnosis and distinguishes CMT1D from other CMT types. MalaCards+1

14. Nerve biopsy with pathology assessment (now less common) – In uncertain cases, a small piece of peripheral nerve (usually sural nerve) may be removed and examined under a microscope. In demyelinating CMT like CMT1D, the pathologist may see segmental demyelination and “onion bulb” formations, which are layers of Schwann cells around axons. This is now used less often because genetic testing is safer and more precise. MalaCards+1

Electrodiagnostic tests

15. Motor nerve conduction studies – Electrodes are placed on the skin over nerves and muscles, and small electrical pulses are delivered. In CMT1D, motor nerve conduction velocities are markedly slowed, often below about 15–20 meters per second, which is typical for demyelinating neuropathy. The low speed helps distinguish CMT1 from axonal CMT2 types. MalaCards+1

16. Sensory nerve conduction studies – Similar tests are done for sensory nerves. In CMT1D, sensory responses may be low in size or absent, and conduction velocities are reduced. Together with motor studies, this confirms a chronic, symmetric, demyelinating sensorimotor neuropathy. NCBI+1

17. Electromyography (EMG) – A fine needle electrode is placed into muscles to record electrical activity at rest and during contraction. EMG in CMT1D often shows chronic denervation and reinnervation patterns, reflecting long-term axonal involvement secondary to demyelination. EMG helps rule out other muscle diseases. MalaCards+1

18. F-wave and late response studies – Special nerve conduction tests called F-waves and H-reflexes examine conduction along the entire length of motor neurons. In demyelinating neuropathies, these late responses are often prolonged or absent, showing widespread myelin damage along the nerve. MalaCards+1

Imaging tests

19. X-rays of feet and spine – Plain X-rays can show bone and joint changes from long-standing muscle imbalance, such as high arches, claw toes, or scoliosis. While X-rays do not show nerves, they help document structural deformities and guide orthopedic management. Orpha+1

20. MRI or ultrasound of peripheral nerves and spine – Magnetic resonance imaging (MRI) or high-resolution ultrasound can sometimes show thickened peripheral nerves or changes in muscles from chronic denervation. MRI of the spine can also look for other causes of weakness or scoliosis. These imaging tests support the clinical picture but are usually secondary to nerve conduction and genetic testing in diagnosing CMT1D. MalaCards+1

Non-pharmacological Treatments (Therapies and Others)

1. Physiotherapy (Physical Therapy)

Physiotherapy is one of the most important treatments for CMT1D. A physiotherapist teaches stretching, strengthening and balance exercises to keep muscles flexible and as strong as possible. Regular practice slows contractures (muscles and tendons becoming tight) and reduces falls. The purpose is to preserve mobility and independence in daily life. The mechanism is simple: repeated, gentle loading of muscles and joints helps maintain muscle fibers, joint range and nerve-muscle coordination even when nerves are weak. nhs.uk+1

2. Occupational Therapy

Occupational therapists focus on hand function and daily activities like dressing, writing or cooking. They may suggest special grips, pens, cutlery and dressing aids. The purpose is to make everyday tasks easier and safer despite weak hands. The mechanism is to adapt tasks and tools to your abilities, so you use less effort and place less stress on fragile joints and nerves, which helps you stay independent longer. nhs.uk+1

3. Ankle–Foot Orthoses (AFOs) and Leg Braces

AFOs are light plastic or carbon-fiber braces worn inside or over shoes. They support weak ankles, lift the front of the foot, and correct “foot drop.” The purpose is to improve walking pattern and prevent tripping and falls. The mechanism is mechanical: the brace holds the ankle in a stable, slightly flexed position so the toes do not drag, reducing energy use and joint strain during walking. Mayo Clinic+1

4. Custom Shoes and Insoles

Custom-made shoes and insoles are shaped to support high arches, hammertoes and wide forefeet, which are common in CMT1D. The purpose is to spread body weight evenly and protect skin from pressure points and calluses. The mechanism is by changing how forces pass through the foot during standing and walking, which reduces pain, slows deformity and lowers ulcer risk. Mayo Clinic+1

5. Thumb and Hand Splints

Soft or rigid splints can support weak thumb and finger joints, especially when fine grip is needed. The purpose is to stabilize joints so you can pinch, grasp and hold objects more safely. The mechanism is biomechanical support: the splint restricts unwanted joint movement and lets the small remaining muscles work more effectively, improving function and reducing fatigue. Mayo Clinic+1

6. Strength Training (Low to Moderate Intensity)

Gentle strengthening with bands or light weights can help maintain muscle size and power in partly-weak muscles. The purpose is to delay disability and support joints. The mechanism is that repeated, low-load contractions stimulate remaining motor units without over-fatiguing damaged nerves. Over-aggressive training is avoided because it may cause overuse weakness. Lippincott Journals+1

7. Stretching and Range-of-Motion Exercises

Daily stretching of calves, hamstrings, hip flexors, hands and toes keeps joints moving. The purpose is to prevent contractures and fixed deformities that can later require surgery. The mechanism is gentle, regular elongation of muscles and tendons, which reduces stiffness, preserves joint motion and improves walking efficiency. nhs.uk+1

8. Balance and Gait Training

Physiotherapists use balance boards, tandem walking and safe obstacle courses to train balance and gait. The purpose is to reduce falls and fear of movement. The mechanism is neuroplasticity: repeated balance challenges help the brain and remaining nerves learn new motor patterns and make better use of visual and inner-ear (vestibular) inputs when sensation in the feet is poor. Lippincott Journals+1

9. Aquatic Therapy (Hydrotherapy)

Exercise in a warm pool supports body weight and reduces joint stress. The purpose is to allow safe walking, strengthening and stretching when land exercise is too difficult. The mechanism comes from buoyancy, which unloads joints, and water resistance, which provides gentle, even resistance to movement, improving strength and cardiovascular fitness with less pain. Lippincott Journals

10. Walking Aids (Canes, Walking Sticks, Rollators)

Canes or walkers are sometimes needed when balance and strength decline. The purpose is to improve stability and confidence outdoors and on uneven surfaces. The mechanism is simple weight-sharing: part of the body weight is transferred to the device, widening the base of support and lowering the chance of falls and fractures. MSD Manuals+1

11. Pain Psychology and Cognitive-Behavioral Therapy (CBT)

Chronic neuropathic pain and fatigue can cause anxiety, low mood and sleep problems. CBT and other pain-focused psychology help people change unhelpful thoughts and coping behaviors. The purpose is to reduce the suffering and disability caused by pain, even if the pain itself does not fully go away. The mechanism is through brain pathways that control attention, emotion and pain modulation. Charcot-Marie-Tooth Association+1

12. Sleep Hygiene and Fatigue Management

Regular sleep times, limiting screens before bed, and pacing daytime activity help with CMT-related fatigue. The purpose is to improve energy, mood and pain tolerance. The mechanism is by stabilizing the body clock, deepening sleep stages and preventing “boom-and-bust” activity cycles that worsen fatigue and pain. Wiley Online Library+1

13. Vocational and School Counseling

As CMT1D progresses, some jobs or school tasks may need adjustments. Vocational and educational counseling help plan realistic careers and accommodations. The purpose is to maintain participation in work or school. The mechanism involves matching tasks to your abilities, arranging assistive technology and ensuring legal protections for disability accommodations. MSD Manuals+1

14. Regular Foot Care and Podiatry

Because feeling in the feet is reduced, small injuries can be missed. Podiatrists trim nails safely, remove calluses and check for skin damage. The purpose is to prevent ulcers, infections and later amputations. The mechanism is early detection: frequent checks find problems when they are still small and easy to treat. MSD Manuals+1

15. Weight Management and Low-Impact Aerobic Exercise

Cycling, swimming or brisk walking, as tolerated, help control weight and improve heart health. The purpose is to reduce extra load on weak legs and lower cardiovascular risk. The mechanism is improved metabolism and circulation; less body weight means less stress on joints and less effort with every step. Lippincott Journals+1

16. Falls-Prevention Home Modifications

Removing loose rugs, adding grab bars, improving lighting and using non-slip mats reduce home hazards. The purpose is to cut the risk of falls and fractures. The mechanism is environmental: by reducing tripping and slipping risks, a person with weak ankles and poor sensation can move more safely at home. MSD Manuals+1

17. Assistive Technology (Voice Recognition, Adaptive Keyboards)

Computers and phones can be adapted for weak hands with voice-to-text, large-key keyboards and trackballs. The purpose is to keep communication, study and work possible even with advanced hand weakness. The mechanism is by replacing fine finger movements with larger, easier actions or voice, reducing strain on small hand muscles. PMC+1

18. Peer Support Groups and Patient Organizations

Joining CMT support groups (online or local) helps people share practical tips and emotional support. The purpose is to reduce isolation, anxiety and depression and to learn about new trials and therapies. The mechanism is social and psychological: feeling understood and informed improves coping and adherence to treatment. Charcot-Marie-Tooth Association+1

19. Education About Toxic Medications

Some chemotherapy drugs and other medicines can worsen CMT. Guidelines list “toxic” drugs to avoid or use carefully. The purpose is nerve protection. The mechanism is preventive: by avoiding medicines that damage peripheral nerves, you reduce the chance of sudden, severe worsening of weakness and sensation. www.elsevier.com+1

20. Genetic Counseling

Because CMT1D is inherited, genetic counseling helps families understand the pattern of inheritance, testing options and pregnancy planning. The purpose is informed decision-making. The mechanism is educational: counselors explain risks in simple terms, discuss choices and coordinate with neurologists and genetic labs. www.elsevier.com+1

---

Drug Treatments

Very important: There is no FDA-approved drug that cures or stops CMT1D. The drugs below mainly treat neuropathic pain, muscle spasms, sleep problems, mood and other complications. Doses here are typical adult ranges from FDA labels or guidelines, but your doctor must adjust them for age, kidney function and other medicines. PMC+2ScienceDirect+2

1. Gabapentin (Neurontin and generics)

Gabapentin is an anti-seizure medicine widely used for neuropathic pain. FDA-approved uses include postherpetic neuralgia (nerve pain after shingles) and epilepsy. Typical adult neuropathic pain dosing starts at 300 mg once daily and increases to 300 mg three times daily, with some patients needing up to 1800–3600 mg/day. The purpose in CMT1D is to reduce burning, shooting and tingling pain. The mechanism involves binding to calcium channel subunits in nerve cells and reducing release of excitatory neurotransmitters. Common side effects are dizziness, sleepiness and swelling of ankles. FDA Access Data+2FDA Access Data+2

2. Pregabalin (Lyrica, Lyrica CR, generics)

Pregabalin is related to gabapentin and is FDA-approved for several neuropathic pain conditions, fibromyalgia and as add-on therapy for seizures. For neuropathic pain, adult dosing often begins at 150 mg/day in divided doses and may increase to 300–600 mg/day, depending on response and kidney function. The purpose in CMT1D is similar: dampen nerve pain and improve sleep. The mechanism is binding to the same calcium channel subunit as gabapentin, reducing abnormal nerve firing. Side effects include dizziness, sleepiness, weight gain and leg swelling. FDA Access Data+2FDA Access Data+2

3. Duloxetine (Cymbalta, Drizalma Sprinkle, generics)

Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant. It is FDA-approved for diabetic neuropathic pain, fibromyalgia, chronic musculoskeletal pain and depression. Adults often start at 30 mg once daily and may increase to 60 mg/day. The purpose in CMT1D is to lessen neuropathic pain and improve mood. The mechanism is boosting serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord. Side effects can include nausea, dry mouth, sweating and increased risk of suicidal thoughts in some young people, so close medical supervision is needed. FDA Access Data+2FDA Access Data+2

4. Amitriptyline (Tricyclic Antidepressant)

Amitriptyline is an older antidepressant often used at low doses at night for nerve pain and insomnia. Typical pain doses may be 10–25 mg at bedtime, slowly increased if tolerated. The purpose in CMT1D is to reduce pain and help sleep. The mechanism is blocking reuptake of serotonin and norepinephrine and also blocking some pain-related receptors. Side effects include dry mouth, constipation, drowsiness, weight gain and rare heart rhythm problems; there is also a boxed warning about suicidal thoughts in young people. FDA Access Data+1

5. Nortriptyline

Nortriptyline is a related tricyclic antidepressant with a somewhat “cleaner” side-effect profile than amitriptyline. Low doses, such as 10–25 mg at night, are often used for neuropathic pain. The purpose is similar: improve sleep and reduce burning pain. The mechanism is also serotonin and norepinephrine reuptake blockade with effects on pain-modulating pathways. Side effects include dry mouth, constipation, dizziness and possible heart rhythm changes at higher doses. ScienceDirect+1

6. Topical Lidocaine 5% Patch

Lidocaine patches are placed on painful skin areas up to 12 hours per day. They are FDA-approved for postherpetic neuralgia but used off-label for focal neuropathic pain. The purpose in CMT1D is to numb small painful skin zones, especially where braces or shoes rub. The mechanism is local sodium channel blockade in peripheral nerves, which reduces nerve firing. Side effects are usually mild skin irritation or rash. Charcot-Marie-Tooth Association+1

7. Capsaicin Topical (Cream or High-Dose Patch)

Capsaicin from chili peppers is used in creams or high-dose patches to treat localized neuropathic pain. It works by overstimulating and then desensitizing pain fibers in the skin. The purpose in CMT1D is to decrease burning pain in specific areas. The mechanism is depletion of substance P and reduced function of TRPV1 pain receptors. Side effects include burning or stinging in the first days of use. Charcot-Marie-Tooth Association+1

8. Baclofen (Kemstro, Ozobax, Lyvispah, others)

Baclofen is a muscle relaxant and antispastic agent. It is FDA-approved for spasticity due to multiple sclerosis and spinal cord disorders, but it is also used for painful muscle cramps. Oral dosing often starts at 5 mg three times per day and is slowly increased as needed. The purpose in CMT1D is to ease painful muscle spasms and stiffness. The mechanism is activation of GABA_B receptors in the spinal cord, reducing excitatory signals to muscles. Side effects include drowsiness, weakness and, with sudden stop, serious withdrawal symptoms. FDA Access Data+2FDA Access Data+2

9. Tizanidine

Tizanidine is another muscle relaxant used for spasticity. It can help nocturnal cramps and stiffness in some CMT patients. Doses start low (for example, 2 mg) at bedtime and are increased slowly. The purpose is symptom relief of cramps that disturb sleep. The mechanism is α2-adrenergic agonist action in the spinal cord, which reduces motor neuron firing. Side effects include sleepiness, low blood pressure and dry mouth. PMC+1

10. Tramadol

Tramadol is a weak opioid and monoamine reuptake inhibitor used for moderate neuropathic pain when first-line drugs fail. Doses are usually kept as low as possible and short-term. The purpose in CMT1D is rescue treatment for severe pain flares. The mechanism combines mild opioid receptor activation with increased serotonin and norepinephrine, which modulate pain. Side effects include nausea, dizziness, constipation and dependence risk, so careful doctor supervision is essential. ScienceDirect+1

11. NSAIDs (e.g., Ibuprofen, Naproxen)

Non-steroidal anti-inflammatory drugs are mainly for musculoskeletal pain, not pure nerve pain. They can help when joint strain or inflammation is present due to deformities or altered gait. The purpose is relief of mild to moderate bone and joint pain. The mechanism is COX enzyme inhibition, which reduces inflammatory prostaglandins. Side effects include stomach upset, kidney strain and bleeding risk at high doses or long use. Medscape eMedicine+1

12. Acetaminophen (Paracetamol)

Acetaminophen is used for mild pain or in combination with other drugs. It does not treat neuropathic pain directly but can reduce musculoskeletal discomfort. The purpose is simple background pain control. The mechanism is central inhibition of pain pathways, though the exact mechanism is still not fully understood. The main safety concern is liver toxicity if total daily dose is exceeded. ScienceDirect

13. Serotonin–Norepinephrine Reuptake Inhibitors Other Than Duloxetine (e.g., Venlafaxine)

Other SNRIs may be used for neuropathic pain and depression when duloxetine is not tolerated. Dosing is individualized and increased gradually. The purpose is to treat both mood and pain, which often occur together in CMT1D. The mechanism is similar to duloxetine: boosting descending pain-control pathways in the brain and spinal cord. Side effects include nausea, sweating, increased blood pressure and risk of suicidal thoughts in young patients. ScienceDirect+1

14. Selective Serotonin Reuptake Inhibitors (SSRIs)

SSRIs such as sertraline or fluoxetine do not strongly treat neuropathic pain, but they are used for depression and anxiety related to chronic illness. The purpose is mainly emotional support, which indirectly improves pain coping. The mechanism is increasing serotonin levels in the brain. Side effects vary but may include stomach upset, sleep changes and sexual side effects. ScienceDirect+1

15. Short-Term Benzodiazepines (e.g., Clonazepam)

In selected cases, benzodiazepines may be used short-term for severe anxiety, muscle spasms or sleep problems. Doses are kept low and time-limited due to dependence risk. The purpose is crisis control of severe symptoms. The mechanism is strengthening GABA-A signaling, which calms brain and spinal cord activity. Side effects include sedation, memory problems and tolerance. ResearchGate+1

16. Melatonin or Other Sleep Aids

Melatonin supplements or doctor-chosen sleep medicines may help with insomnia from pain or cramps. The purpose is to restore regular, restful sleep, which can reduce daytime pain and fatigue. The mechanism is regulating the body clock or enhancing sleep drive. Side effects vary but melatonin is usually well tolerated at low doses. Charcot-Marie-Tooth Association+1

17. Topical NSAID Gels

Topical diclofenac and similar gels can be applied to painful joints or tendons around deformed feet or ankles. The purpose is local pain relief with less whole-body exposure. The mechanism is local anti-inflammatory action in tissues near the application site. Side effects are usually skin irritation; systemic side effects are less common than with oral NSAIDs. Medscape eMedicine+1

18. Magnesium Supplements (for Cramps – Under Doctor Advice)

Some doctors use magnesium to help muscle cramps, though evidence is mixed. Dosing must be adjusted for kidney function. The purpose is to reduce nocturnal cramps that disturb sleep. The mechanism may involve stabilizing nerve and muscle membranes. Too much magnesium can cause diarrhea or heart rhythm issues, so medical guidance is important. PMC

19. Vitamin D (If Deficient)

Vitamin D deficiency is common and can worsen muscle weakness and bone health. When blood tests show low levels, supplements are given. The purpose is to support bone strength and muscle function. The mechanism is improved calcium absorption and bone mineralization. High doses without testing can be harmful, so dosing must be guided by blood levels. PMC+1

20. Vaccines (e.g., Flu, Pneumonia, COVID-19 as National Guidelines)

Vaccines are not specific to CMT1D but are important to prevent infections that could cause long hospital stays and worsening mobility. The purpose is to reduce infection risk and complications. The mechanism is immune priming against specific viruses or bacteria. Side effects are usually mild and short-term, like sore arm or low-grade fever. ScienceDirect

---

Dietary Molecular Supplements

Evidence for supplements in CMT1D is limited; most data are from general nerve health or other neuropathies. They should not replace prescribed medicines. PMC+1

1. Alpha-Lipoic Acid – An antioxidant that may help diabetic neuropathy by reducing oxidative stress around nerves. Typical doses in studies are about 300–600 mg/day. It may support nerve blood flow and energy production in mitochondria. Side effects can include stomach upset and low blood sugar in some people.

2. Acetyl-L-Carnitine – Supports mitochondrial energy production and may help nerve regeneration in some studies. Doses are often 500–1000 mg two or three times daily. It may improve nerve conduction and reduce pain, but evidence in CMT is limited. Possible side effects include nausea and restlessness.

3. Coenzyme Q10 (CoQ10) – A mitochondrial cofactor and antioxidant. Common doses are 100–300 mg/day. It may support muscle and nerve energy production and reduce oxidative damage. Side effects are usually mild, such as stomach upset.

4. Omega-3 Fatty Acids (Fish Oil or Algae Oil) – EPA/DHA may reduce inflammation, support nerve membranes and improve heart health. Doses vary (for example, 1–2 g/day of EPA/DHA). Side effects can include fishy aftertaste and, rarely, bleeding risk at high doses.

5. B-Complex Vitamins (B1, B6, B12) – These vitamins are essential for nerve function. When deficiency is present, replacement can improve neuropathy symptoms. Doses depend on blood levels. Replacement corrects metabolic problems in the nerve and supports myelin repair. Too much B6 can itself cause neuropathy, so dosing must be monitored.

6. Vitamin D – As above, used when deficiency is documented, often 800–2000 IU/day or as prescribed. Supports bone and muscle, reduces fracture risk and may indirectly help mobility. Overdosing can cause high calcium and kidney problems.

7. Vitamin E – A fat-soluble antioxidant that protects cell membranes. It is mainly useful when a true deficiency exists (for example, in some malabsorption disorders). High doses without deficiency are not clearly beneficial and can increase bleeding risk.

8. Magnesium (Oral) – When deficiency is documented, magnesium replacement can support nerve and muscle function. Typical doses might be 200–400 mg/day, adjusted for kidney function. Too much can cause diarrhea or dangerous heart rhythm changes.

9. Curcumin (Turmeric Extract) – Has anti-inflammatory and antioxidant properties in lab studies. Some people take standardized curcumin supplements to help joint or muscle discomfort. Human evidence in CMT is weak, and high doses can upset the stomach or interact with blood thinners.

10. Resveratrol or Other Polyphenols – Plant polyphenols have antioxidant and anti-inflammatory actions in experimental models. They are sometimes used for general “nerve health,” but strong clinical data in CMT are lacking. They should be seen as supportive at best and not as a cure. PMC+1

---

Regenerative / Immunity-Related / Stem Cell–Type Drugs

At present, there are no FDA-approved stem cell or regenerative medicines specifically for CMT1D. Below are general research or supportive approaches, not standard treatments. They should only be considered in clinical trials or under specialist care. PMC+1

1. Intravenous Immunoglobulin (IVIG) – Useful in autoimmune neuropathies, but CMT1D is genetic, not immune. IVIG is sometimes discussed when diagnosis is unclear. It modulates immune activity and can neutralize harmful antibodies. In CMT1D, it is usually not effective, so it is rarely used once the genetic diagnosis is clear.

2. Corticosteroids and Other Immunosuppressants – Effective for inflammatory neuropathies, but not for purely genetic CMT1D. They suppress immune cells and cytokines. In CMT1D, their use is generally avoided because benefits are doubtful and side effects are significant (bone thinning, weight gain, infection risk).

3. Experimental Gene-Targeted Therapies – Research is exploring gene therapy and RNA-based treatments for some CMT subtypes. The idea is to correct or silence the faulty gene in Schwann cells. For CMT1D, this is still theoretical and limited to early-phase or animal studies.

4. Neurotrophic Factors (e.g., NGF, BDNF) in Research – Growth factors that support nerve survival have been studied in animal models. They promote regeneration and myelin repair but have not yet translated into routine clinical use because of delivery and safety issues.

5. Mesenchymal Stem Cell Trials – Some trials in other neuropathies test stem cells for their ability to release growth factors and modulate inflammation. For CMT1D, participation in a regulated clinical trial is the only safe route; outside trials, these approaches are experimental and sometimes risky.

6. Future Gene Editing (CRISPR-Based) – Early research suggests that gene editing might one day correct disease-causing variants in hereditary neuropathies. At present, this remains in preclinical or very early clinical stages and is not available as treatment.

---

Surgeries –  Main Procedures

Surgery does not cure CMT1D but can correct severe deformities and improve function or shoe-wearing. Decisions are made with an experienced orthopedic foot/ankle surgeon or hand surgeon. Medscape eMedicine+2MSD Manuals+2

1. Soft Tissue Releases (Tendon Lengthening, Plantar Fascia Release) – Tight tendons and fascia under the foot can lock the foot in a high-arched position. Surgeons cut or lengthen these tissues to allow the foot to sit flatter in shoes. This is done to relieve pain, reduce pressure points and improve gait.

2. Tendon Transfers – In tendon transfer, a stronger, functioning tendon is moved to take over the job of a weaker or paralyzed tendon. For example, a tendon that lifts the toes may be moved to help lift the ankle. The aim is to balance muscle forces, improve foot position and reduce foot drop.

3. Osteotomies (Bone Cuts and Realignment) – When foot bones are severely twisted, surgeons cut and reposition them to create a more stable arch and plantigrade foot (flat on the ground). This can make walking safer, improve shoe fit and lower ulcer risk.

4. Joint Fusions (Arthrodesis) – In very unstable or painful joints, surgeons permanently fuse bones together so the joint no longer moves. This sacrifices some flexibility but can give a strong, pain-free base for walking. The decision is usually made after other options have failed.

5. Hand Surgery (Tendon Transfers and Joint Stabilization) – For severe hand deformities and clawing, surgeons may transfer tendons or fuse joints to improve pinch and grip. The goal is functional: making essential tasks like holding a cup or writing easier and less painful.

---

Preventions

1. Avoid Nerve-Toxic Medicines (especially certain chemotherapy drugs) whenever alternatives exist.

2. Use Braces and Orthotics as Prescribed to prevent falls and slow deformity.

3. Do Daily Stretching and Home Exercise to prevent contractures and stiffness.

4. Protect Feet with well-fitting shoes and daily skin checks to spot early sores.

5. Stay Physically Active Within Limits to keep muscles and heart strong.

6. Maintain Healthy Weight to reduce stress on weak legs and feet.

7. Create a Safe Home Environment (no loose rugs, good lighting, grab bars in bathroom).

8. Avoid Smoking and Excess Alcohol, which can further damage nerves and circulation.

9. Keep Vaccinations Updated as advised to avoid severe infections and hospital stays.

10. Attend Regular Follow-Up Visits with neurology and rehabilitation teams to adjust treatments early. www.elsevier.com+3nhs.uk+3MSD Manuals+3

---

When to See Doctors

You should see a neurologist or your regular doctor if you notice new or rapidly worsening weakness, more frequent falls, sudden change in walking, new severe pain, or new problems with bladder or bowel control. These may be signs of complications or another condition on top of CMT1D. You should also seek help if pain medicines are not working, side effects appear (like extreme drowsiness, mood changes, swelling or allergic reactions), or if braces or shoes are causing skin injury. Regular review with physiotherapy, orthopedic and genetic clinics is important, even when you feel stable, because early adjustments often prevent bigger problems later. Mayo Clinic+2MSD Manuals+2

---

What to Eat and What to Avoid

1. Eat: A balanced diet rich in fruits, vegetables, whole grains and lean proteins to support overall health, energy and muscle repair.

2. Eat: Foods with omega-3 fats (fatty fish, walnuts, flaxseed) to support heart health and possibly nerve membranes.

3. Eat: Calcium and vitamin D sources (dairy or fortified alternatives, leafy greens) for strong bones.

4. Eat: Adequate protein (beans, lentils, eggs, fish, poultry) to maintain muscle mass.

5. Eat: Enough fluids and fiber (whole grains, fruits, vegetables) to prevent constipation, which some medicines can worsen.

6. Avoid: Large amounts of alcohol, which can damage nerves and worsen balance.

7. Avoid: Heavy, highly processed, salty and sugary foods that promote weight gain and cardiovascular disease.

8. Avoid: Crash diets that cause rapid weight loss and muscle wasting.

9. Avoid: Very high-dose supplements without blood tests and medical advice, because some vitamins in excess can harm nerves or organs.

10. Avoid: Smoking and second-hand smoke, which damage blood vessels and reduce oxygen delivery to nerves and muscles. PMC+1

---

Frequently Asked Questions (FAQs)

1. Is there a cure for Charcot-Marie-Tooth neuropathy type 1D?
   No. At this time there is no cure or disease-stopping drug for CMT1D. Treatment focuses on relieving symptoms, protecting joints and nerves and helping you stay as active and independent as possible. Researchers are working on gene-based and regenerative therapies, but these are still in early stages. PMC+1

2. Can exercise make CMT1D worse?
   Correct, gentle exercise usually helps rather than harms. Over-heavy, high-impact training may overstress weak muscles and joints. A physiotherapist can design a safe program with stretching, low-impact strength and balance work to maintain function without overuse injury. Lippincott Journals+1

3. Why do I need braces or orthotics?
   Braces and orthotics support weak muscles, prevent falls and protect joints from abnormal loading. They may feel strange at first, but they often reduce pain and improve walking over time. Using them early can slow the development of fixed deformities that may later need surgery. Mayo Clinic+2MSD Manuals+2

4. Will surgery stop my CMT from progressing?
   No. Surgery can correct foot or hand deformities and reduce pain, but it does not change the underlying genetic nerve problem. Nerves may still slowly worsen, so physiotherapy, braces and medical follow-up remain important even after a successful operation. Medscape eMedicine+1

5. Why do I have pain if my nerves are dying?
   In CMT1D, damaged nerves can become overactive and send wrong signals to the brain. This causes burning, shooting or electric-shock pain even without injury. Pain medicines and non-drug methods try to calm these abnormal signals and help the brain filter them better. Wiley Online Library+1

6. Which pain medicine is “best” for CMT1D?
   There is no single best drug for everyone. Guidelines for neuropathic pain often start with gabapentin or pregabalin, SNRIs like duloxetine, or tricyclic antidepressants such as amitriptyline, chosen based on age, other illnesses and side-effect risk. Often a combination of medicines plus non-drug methods works best. ScienceDirect+2www.elsevier.com+2

7. Can diet alone treat CMT1D?
   Diet cannot cure or stop CMT1D, but healthy eating supports muscles, bones, weight control and general wellbeing. This makes it easier to exercise and reduces other health problems that would further limit mobility. Supplements may help when there is a proven deficiency, but they do not replace medical care. PMC+1

8. Is CMT1D life-threatening?
   Most people with CMT live a normal life span, but disability level varies widely. Some use braces only, while others eventually need wheelchairs. Life-threatening complications are uncommon and usually linked to severe falls, infections, or unrelated illnesses, so prevention and regular medical care are important. MSD Manuals+1

9. Can I have children if I have CMT1D?
   Yes, many people with CMT have children and families. However, there is a risk of passing the condition on, depending on the exact gene and inheritance pattern. Genetic counseling can explain these risks and discuss options like prenatal testing or pre-implantation genetic testing. www.elsevier.com+1

10. Are there medicines I should avoid?
    Some medicines, especially certain chemotherapy drugs, can be particularly toxic to peripheral nerves and may worsen CMT. Your neurologist can provide an up-to-date list. Always tell doctors and dentists that you have CMT before starting new medicines. www.elsevier.com+1

11. Why do I feel so tired all the time?
    Fatigue is common in CMT because weak muscles work harder for every step, and chronic pain and poor sleep drain energy. Treating pain, improving sleep, using braces or aids and pacing activities usually helps. Sometimes mood disorders also need treatment. Wiley Online Library+1

12. Can CMT1D affect my breathing or heart?
    Most people with CMT1D have mainly limb involvement, but some severe or long-standing cases can develop breathing or scoliosis-related issues. Any new shortness of breath, morning headaches or sleep apnea symptoms should be checked promptly. Heart involvement is less common but should be monitored if your doctor is concerned. PMC+1

13. Is it safe to join clinical trials?
    Clinical trials are the only safe way to try experimental treatments. They are supervised under strict ethical and safety rules. Before joining, you should understand the potential risks and benefits, what is known from earlier studies and what tests will be done. Your neurologist or a CMT center can guide you. ResearchGate+1

14. What kind of specialists should be in my care team?
    An ideal CMT1D team includes a neurologist, physiotherapist, occupational therapist, orthopedic surgeon, orthotist, podiatrist, pain specialist and, when needed, a psychologist and genetic counselor. Working together, they can design a personalized, step-by-step plan to support you through different stages of the disease. PMC+1

15. What is the most important thing I can do right now?
    For many people, the most powerful steps are: stay engaged with care (regular follow-ups), use braces or aids if advised, do safe home exercises and stretching, protect your feet and prevent falls, and ask for help early when pain, mood or function change. Early action often prevents bigger problems later on. nhs.uk+2MSD Manuals+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 25, 2025.